Isoxsuprine%25252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252520hydrochloride

# Isoxsuprine hydrochloride ## Overview Isoxsuprine hydrochloride is a peripheral vasodilator. Its mechanism of action is not fully understood but is thought to involve direct relaxation of vascular smooth muscle, leading to vasodilation. ## Primary Indications * Treatment of peripheral vascular disease, including intermittent claudication and Raynaud's disease. * Management of cerebrovascular insufficiency. ## Adult Dosing * **Oral:** 10 mg to 20 mg three to four times daily. * **Maximum Dose:** Not explicitly defined, but doses exceeding 20 mg four times daily are generally not recommended. ## Pediatric Dosing * No established pediatric dosing. ## Dose Adjustments * No specific dose adjustments are typically required for renal or hepatic impairment, although caution should be exercised and monitoring for adverse effects is advised. ## Contraindications * Hypersensitivity to isoxsuprine. * Use immediately postpartum. * Use in patients with congenital heart disease. * Concomitant administration with agents that may lower blood pressure. ## Adverse Effects * **Common:** Nausea, vomiting, gastrointestinal distress, dizziness, weakness, flushing, headache, rash. * **Less Common/Severe:** Hypotension, tachycardia, palpitations, drowsiness. ## Key Drug Interactions * **Antihypertensives:** Isoxsuprine may potentiate the hypotensive effects of antihypertensive medications. * **Other Vasodilators:** Concomitant use may lead to additive hypotensive effects. ## Monitoring * Monitor for signs and symptoms of hypotension, including dizziness and lightheadedness. * Assess for improvement in peripheral circulation (e.g., reduced claudication pain, improved skin temperature). * Observe for gastrointestinal distress and other adverse effects. ## Clinical Pearls * Effectiveness in peripheral vascular disease can vary significantly between individuals. * Therapeutic response may take several weeks to become apparent. * Should be discontinued if no demonstrable benefit is observed after a reasonable trial period. --- *This information is intended for clinical use and does not substitute for professional medical judgment. Always verify current prescribing information with the official product monograph or reliable drug compendia.*